Facebook
Twitter
LinkedIn
Forward
0545_Sutter Health Neurosciences Grand Rounds_Update on Migraine Headaches_Live
Description:
Migraines are often complex, involving a combination of genetic, environmental, neurological factors and their chronic nature can lead to significant disability. Optimal migraine management requires a comprehensive approach, integrating pharmacological treatments, lifestyle modifications, and personalized care strategies. Neuroscience professionals play a pivotal role in diagnosing, monitoring, and adjusting treatments for individuals, helping to reduce the frequency and severity of attacks. This activity reviews the pathophysiology, diagnosis, and management of migraines by providing healthcare providers with comprehensive knowledge about the latest evidence-based strategies for acute treatment, preventive therapies, and patient-centered approaches to care.
Target Audience
Physicians (MD or DO)
Physician Assistant (PA)
Other Healthcare Professionals
Learning Objectives
After completing this activity, learners will be able to:
1.) Identify three classes of preventative migraine medications
2.) Identify two classes of acute medications
3.) Explain the three tiers of migraine management (pyramid approach)
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Stewart, W. F., et al. “Migraine Prevalence, Socioeconomic Status, and Social Causation.” Neurology, vol. 81, no. 11, 29 Aug. 2013, pp. 948–955, https://doi.org/10.1212/wnl.0b013e3182a43b32.
- Kiarashi, J., VanderPluym, J., Szperka, C. L., Turner, S., Minen, M. T., Broner, S., ... & Charleston IV, L. (2021). Factors associated with, and mitigation strategies for, health care disparities faced by patients with headache disorders. Neurology, 97(6), 280-289.
- Monteith, T. S. (2022). Advocacy for migraine relief: strategic planning to eliminate the burden. Current pain and headache reports, 26(8), 567-574.
- Charleston IV, L. (2021). Headache disparities in African-Americans in the United States: a narrative review. Journal of the National Medical Association, 113(2), 223-229.
Gnanagurudasan Prakasam, MD, a planning team member for this activity, receives consultant fees from Novo Nordisk (related to growth hormones), Medtronic (related to insulin pumps), Dexcom (related to glucose sensors), Mannkind (related to inhaled insulin), Alexion (related to HPP), and K Kirin (related to XLH) as well as speaker fees from Lilly (related to diabetes), Sanozi (related to Diabetes Type 1 prevention), and Abbvie (related to puberty). These ineligible relationships were deemed not relevant to this activity’s topic, and thus mitigation was not needed.
Sophia Humphreys, PharmD, a planning team member for this activity has recently ended financial relationships with the following ineligible companies: Pharmacosmos (ended 12/2023), Fresenius Kabi (ended 10/2022), and Heron (ended 10/2022).
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
Additional faculty involved the planning of this learning activity are as follows:
Carolin Delker, NP
Max Ingersoll, FNP-BC, MSN
Jill Kacher Cobb, MD
Tam Nguyen, MD
Lori Petrini
Michelle Mah
Luanne Ridgley, LSW
Christopher Mack
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Kenneth Laxer, MD, FAAN, FAES, FANA
Kenneth Laxer, MD, FAAN, FAES, FANA
Sheena Pillai, MD
Sheena Pillai, MD
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.